While most are approved for the management of type 2 diabetes, some formulations, such as semaglutide (Wegovy) and tirzepatide (Zepbound), have also been approved for chronic weight management in adults with obesity or overweight
Add 20-30 minutes of daily walking if not already active
Those treated with an SGLT2i were more than twice as likely to develop a UTI or pyelonephritis than those treated with a GLP-1 RA (RR 2.27 [95% CI 1.12, 4.55] p =0.019)
For most patients over 40 with mixed goals (fat loss, anti-aging, and recovery), CJC-1295/Ipamorelin is the most commonly recommended starting protocol because of its broad effects across the systems most affected by age-related GH decline
This finding is consistent with the broader observation that GHS-R1a receptors are expressed in multiple tissues beyond the pituitary, including kidney, heart, and immune cells, suggesting pleiotropic protective functions
Kelly Chauvin, PharmD Medical Science Liaison Adherence Monitoring and Measurement Laboratory testing plays a crucial role in monitoring patients on medications including GLP-1 RAs for weight loss to ensure both efficacy and safety of the treatment plan